Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients

Acta Cardiologica

Volumn 56, Issue 5, 2001, Pages 289-295

  Guasti, L ^a   Petrozzino, M R ^a   Mainardi, L T ^a   Grimoldi, P ^a   Zanotta, D ^a   Garganico, D ^a   Diolisi, A ^a   Simoni, C ^a   Grandi, A M ^a   Gaudio, G ^a   Cerutti, S ^a   Venco, A ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Baroreflex sensitivity; Essential hypertension; RR variability; Spectral analysis

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LOSARTAN;

ADULT; ARTICLE; AUTONOMIC INNERVATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; FOLLOW UP; HEART RATE VARIABILITY; HUMAN; PRESSORECEPTOR REFLEX; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; REST; SPECTROSCOPY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0034793405     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.56.5.2005689     Document Type: Article

References (49)

1. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure
2. Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension
3. Sympathetically mediated vasoconstriction is augmented by angiotensin II in man
4. Angiotensin peptides and baroreflex control of sympathetic outflow: Pathways and mechanisms of the medulla oblongata
5. Role of angiotensin II and catecholamines in blood pressure variability response to stress in SHR
6. Pressure-independent baroreflex resetting produced by chronic infusion of angiotensin II in rabbits
7. Heart rate variability. Standards of measurements, physiological interpretation, and clinical use
8. Power spectral analysis of heart rate variability: A noninvasive signature of cardiac autonomic function
9. Power spectrum analysis of heart rate variability to assess changes in sympathovagal balance during graded orthostatic tilt
10. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat to beat cardiovascular control
11. Assessment of autonomic function in humans by heart rate spectral analysis
12. Cardiovascular neural regulation explored in the frequency domain
13. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans
14. Assessment of baroreceptor reflex sensitivity by means of spectral analysis
15. Changes in autonomic regulation induced by physical training in mild hypertension
16. Cardiovascular neural regulation explored in the frequency domain
17. Autonomic function and baroreflex sensitivity during a normal ovulatory cycle in humans
18. Identification techniques applied to processing of signals from cardiovascular system
19. Twenty-four hour noninvasive blood pressure monitoring and pain perception
20. Relationship between a genetic predisposition to hypertension, blood pressure levels and pain sensitivity
21. Plasma and urinary catecholamines during the human ovulatory cycle
22. Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle
23. Endogenous angiotensin II and baroreceptor dysfunction: A comparative study of losartan and enalapril in man
24. Neural and hypotensive effects of angiotensin II receptor blockade
25. Sympathetic predominance in essential hypertension: A study employing spectral analysis of heart rate variability
26. Twenty-four hour power spectral analysis of heart rate variability and of arterial pressure values in normotensive and hypertensive subjects
27. Alterations in heart rate variability and its circadian rhythm in hypertensive patients with left ventricular hypertrophy free of coronary artery disease
28. Heart rate variability in systemic hypertension
29. Reflex control of the heart
30. Effect of age and high blood pressure on baroreflex sensitivity in man
31. Reduced baroreceptor sensitivity in borderline hypertension
32. Carotid baroreflex function in young men with borderline blood pressure elevation
33. Consequences of impaired arterial baroreflex in essential hypertension: Effects on pressor responses, plasma noradrenaline and blood pressure variability
34. Baroreceptor control of the circulation in man. An update
35. Non-invasive ambulatory blood pressure variability and cardiac baroreflex sensitivity
36. Angiotensin-converting enzyme inhibitors
37. Pharmacological mechanism of angiotensin II receptor antagonists: Implications for the treatment of elevated systolic blood pressure
38. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension
39. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects
40. Modification of arterial baroreflexes by captopril in essential hypertension
41. Effects of an ACE inhibitor and a calcium channel blocker on cardiovascular autonomic nervous system and carotid distensibility in patients with mild to moderate hypertension
42. Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone
43. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension
44. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure
45. Angiotensin II enhances baroreflex control of sympathetic outflow in heart failure
46. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction
47. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure
48. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
49. Comparison of early and late start of antihypertensive agents and baroreceptor reflexes